It has been known since the time of Alexander Schmidt (32) that thrombin disappears rapidly from the serum after blood clotting. Isolated prothrombin and thrombin preparations vary in stability on keeping and on heating (8, 21, 30) , and thrombinolysis by added trypsin is known to reduce its effectiveness in dotting blood (7, 11) . A study of the kinetics of the reduction in coagulant activity of thrombin preparations, (a) held under controlled physical conditions, (b) as influenced by added trypsin, and (c) in the presence of serum, might be expected to shed light on the mechanism of thrombin inactivation.
tional technical considerations relating to modifications of the methods and the special requirements of the current investigations:
Preservation of Reagents; Apparatus Used; etc.--Low temperatures (ice box) are used for the preservation of solutions. In all cases, a few crystals of thymol are added to prevent bacterial growth. The glass electrode (Beckman pH meter) is used to control pH, and the specified temperatures are maintained (:t:0.5°C.) with a thermostat water bath. A mechanical rocking device and stop watch are used in timing coagulation (see below).
Protkrombin Solutions.--The Howell-type "prothrombin papers," each corresponding to 5 cc. of filtrate from defibrinated (55°C.), Berkefelded, citrated dog plasma, are extracted in the cold for 1-2 hours with distilled water and a drop or two of 0.5 per cent NaHCOn. The pH of the filtered extract is adjusted to pH --7.2 with N/10 acetic acid.
Activity.--In some recent tests, kindly performed for us by Dr. H. P. Smith (Iowa), it was found that the activity of such prothrombin solutions represents some 57 per cent of a corresponding volume of (average) dog plasma. 1 co. of solution (3 papers + 60 co.
water) contained 1.25 rag. (total) N and assayed 47 prothrombin "units" (Smith et al. (36) ); i.e., activity -38 units per mg. N.
The nitrogen (protein) content of the prothrombin solution was sometimes reduced by submitting the above salt-poor extract to isoelectric precipitation (pH --5.3). On redissolving to original volume and routine pH (7.2), there was no significant loss in potency. Other prothrombin methods were tried, e.g. Mellanby's (21) ; also various adsorbed and eluted preparations (e.g. (34) ), without finding any significant modification of the properties to be described. There was a suggestion that preliminary Berkefeld filtration of the plasma favored the subsequent preparation of a more stable prothrombin, but details have not been worked out.
Tkrombin.--Is formed from prothrombin solution by activating to maximal coagulant activity with optimal amounts of N/10 CaCI~ and a thromboplastic agent (cephaliu or brain thromboplastin~ee below). The pH is finally adjusted to 7.0 (unless otherwise stated). Like Mellanby (21) and others (35) , we found that the final thrombin could be precipitated by acetone. The precipitate, whether dried immediately or kept under the acetone, has yielded active preparations, even after several months (ice box).
Tkromboplastin.--The cephalin has been described previously (9) . Mter some 2 years under alcohol it suffered considerable loss of potency and yielded solutions of noticeable acidity. A crude but potent thromboplastin is prepared by grinding up dog brain (fresh or frozen) with distilled water, diluting, and centrifugalizing. A desiccated preparation was also made by precipitating a saline (0.85 per cent NaC1) extract of brain with four volumes of acetone, recovering the deposit on a Bfichner funnel, and drying at room temperature. Aqueous suspensions were made up as required.
Fibrinogen.--(NH4)2SO4-fibrinogen is made from Berkefelded plasma in the usual
way (9) . A low salt content favors a sharp end-point in the clotting test (see below); hence the use of water, rather than saline, as the solvent and the avoidance of citrate (or oxalate), which might be desirable, theoretically, to control traces of prothrombin (8) . Actual tests reveal little or no prothrombin, provided that the fibrinogen is made from Berkefelded plasma several days old and particularly if a well diluted fibrinogen solution is employed. It is unnecessary to resort to the previously recommended adsorption techniques (9) for getting rid of the last traces of prothrombin. Lyophilized fibrinogen (10) has been found to lose all traces of prothrombin on simple keeping, but was not used in the current experiments. A new and easy method of preserving fibrinogen consists in dissolving the final salted-out protein in 20 per cent urea solution. Stored in the ice box, such preparations keep for several weeks. At low temperatures the urea protects the fibrinogen from denaturation, according to Diebold and Jtihling (5) . It is restored to a state closely resembling the original on removing the urea (a) by dialysis through Visking casing or (b) merely by diluting (10-30 times) to a point at which the urea ceases to exert a significant influence on dotting (16) . Traces of prothrombin, if present in the fibrinogen, are apt to be preserved also and occasionally lead to some thrombin formation which causes traces of clot to appear in the recovered fibrinogen. Any unstable fibrinogen preparation, of course, is discarded.
Crystalline Trypsin.--Is now available commercially, t The preparation we used contained 0.022 rag. protein N per rag. of sample.
Serum.--The mode of preparation and testing of serum antithrombin will be described in the appropriate section.
Barbiturate Buffer.--In certain experiments, involving alteration of the pH of the thrombic mixtures, constancy of the hydrogen ion concentration in the actual thrombinfibrinogen interaction was secured by adding an equal volume of N/10 barbital-Na (Michaelis (24) ), at the routine pH (7.2), to the fibrinogen solution, and checking with the glass electrode. We have also used the expensive imidazole buffer recommended by Mertz, Seegers, and Smith (23) , in several of the cited experiments.
Clotting Time and Thrombin Concentration (Relative): the "Inverse Law"
All methods of thrombin (and prothrombin) determination are necessarily relative, since the agent has not yet been defined chemically. In the current investigation, thrombin "concentrations" are initially expressed in terms of the degree of dilution of the same preparation, used as the standard of reference throughout the particular experiment. We have avoided any attempt to transfer the quantitative data from one experiment to another by means of arbitrary thrombin units (cf. 6 ).
The index of activity of thrombin in a given test is the clotting time (see below) for a suitable fibrinogen solution. The dependence of cldotting time upon physical conditions (temperature, pH, salt content, fibrinogen concentration, etc.) makes it imperative to control all these variables throughout each series of tests. The influence of naturally-occurring antithrombins is also an important variable which will receive special consideration in other sections of this paper.
Many previous workers (e.g. 14) have established the general principle known as the inverse law, which states that the clotting time is an inverse (reciprocal) function of thrombin concentration. This expression is analogous to the well known Arrhenius "Qt rule" (1, 2), developed for re- i.e. the product of enzyme concentration E by time y is a constant (K). Alternatively, of thrombin with the enzymes (of. 27), "thrombin" may be substituted for "enzyme" in the mathematical analysis of the data. When applying the formula to coagulation data, we may question the validity of postulating the "given amount of effect," viz. here the identical extent of change in fibrinogen at the moment of coagulation, irrespective of the amount or type of thrombin used. Actually, the only evidence for this is the reasonably close adherence to the inverse law throughout the range of thrombin concentrations with which we are working. There are undoubted empiricisms of technique, particularly in the method of timing the clotting.
We thne the appearance of the first visible strands of fibrin in a relatively weak and salt-poor fibrinogen solution. This timing from the commencement of clotting is readily applicable to the translucent solutions with which we are working. It is particularly valuable for the weakest thrombins, which may fail to cause gel formation. Methods of timing based on solidity (firmness) of the dot (e.g. time when tube can be inverted without spilling the contents), while frequently used for such turbid materials as whole blood, etc., are obviously subject to additional variables such as the adhesiveness and coherence of the fibrin gel and the diameter of the tube used in the clotting test.
To test the applicability of equation 2, serial dilutions of a typical thrombin preparation were used. 0.5 cc. of each dilution was added to 1.0 cc. of weak fibrinogen solution at the routine temperature (20°C.) and pH (7.2) , and the clotting time noted. The results are listed in Table I , Series A.
The product of clotting time by concentration (relative dilution) of thrombin gives a value which is constant within the limits imposed by the experimental technique. Equation 2 does fit the experimental data and, therefore, affords a means of assaying thrombic activity by timing the clot. Thrombin concentrations are henceforth computed from the actual clotting time data, the validity being checked by a similar series of dilution experiments accompanying each of the subsequent investigations. In some of the data, closer agreement with the theoretical conditions is attained by the use of the general formula. Thus, the derived expression for the rate constant (k, equation 6) would be modified to
A more manageable form of equation (il) may be developed from the observation that K (ffi Ey; equation 1) varies directly with E, whence
where c is a constant, determined by the intercept with the Y-axis of the line obtained on plotting K against E, and a is the slope. The modified rate equation now becomes
Kinetics of Thrombin Inactivation: Order of the Reaction
Provided we know the order of the reaction, the rate of the progressive inactivation of thrombin can be defined by the constant of the rate equation. The expression for a first order inactivation process is
or, integrating between the limits of the incubation times tl and ts (and corresponding thrombin concentrations E1 and E~.) where k is the velocity constant for a first order reaction, representing the fraction of thrombin inactivated in unit time (a minute being used as the time unit throughout this paper).
The experimental results of Fig. 1 were obtained in a study of the rate of "spontaneous" inactivation of a thrombin prepared from the Howell-type prothrombin with CaC12 and brain thromboplastin, as described under
That this relation holds more widely than E = K is shown by a comparison of the last y two columns of Table I , especially for Series B. This expression may be used to extend the experimental validity of equation 6. reagents. The clotting time data were substituted into equation 6 .
The values of y are routinely determined from the "best" straight line drawn through the points, using the method of least squares (22) . The calculated k values are given in Fig. 1 .
The values of k for different concentrations of thrombin are constant, within experimental limits. This has been' confirmed repeatedly during these studies. It establishes the fact that the inactivation of thrombin follows the course of a first order reaction. Calculations based upon the assumption of zero order and of second order reactions gave variable values for k.
A generalized formulation of the results iUustrated in Fig. 1 is
This brings out the additional point that, although the fraction of thrombin inactivated in unit time is constant irrespective of the thrombin con- 
Variation of k for Different Tkrombin Preparations
The thrombin preparations were made from the Howell-type prothrombin by activation with CaC1, and the designated thromboplastin. The values for k were obtained at pH 6.0 and 38 °.
Brain extract CephaUn
* Acetone-precipitated thrombin (see reagents).
centration, the rate of increase in the clotting time is greater for weak thrombin preparations than for stronger ones.
Variation of k for Different Tkrombin Preparations: Influence of Thromboplastin
Although many types of active thrombin (crude) have been described in the literature (see section on methods), all preparations are empirical and make no claim to chemical purity. The data summarized in Table II show fairly wide variations of the k value for different thrombin preparations. This is true for a large number and variety of thrombin preparations which have been investigated. It even holds for solutions made on different occasions with exactly similar techniques of preparation. The question Of the possible influence of the type of thromboplastic agent used in activation is especially important in view of the possibility that this may contribute a thrombinolytic factor (in crude tissue extracts, for instance). amount of ~T/10 CaCh and varying amounts of a cephalin preparation. There is some inhibitory effect on thrombin formation with the higher cephalin concentrations, due perhaps to the large excess of cephalin in relation to the weak p~o-thrombin used (8) . The chief effect appears to be immediate, since an analysis of the linear portion ot the inactivation curves shows only a threefold increase in the k value for a 16-fold increase in cephalin concentration. Table III shows the effects of varying amounts of (A) cephalin, added to fully formed thrombin and (B) brain thromboplastin, added to recalcified (15)) had no effect on the velocity constant.
These studies are by no means exhaustive and should be extended to a wider variety of thromboplastic agents. For present purposes, the cited data suffice to uphold the contention that the major factor in the k variations of the individual thrombins is not significantly related to the thromboplastin. The following points are brought out in the data: 1. Below 15°C., the rate of inactivation becomes very small and the increase of k with rise of temperature (as indicated by the Q~o) is very minor. This resembles many enzyme reactions (38) . It also emphasizes the necessity of running clotting tests at low temperatures to prevent loss of thrombic activity (especially during the activation of weak prothrombins) during any prolonged clotting tests (9).
2. Between 20°C. and 40°C., the value of g is of the same order as that obtained in many known chemical and enzymatic reactions (e.g. 38).
3. Above 50°C. (especially near 60°C.), the value of it increases mark-edly to over 40,000 calories per mol (at constant pH). Such high values (under similar conditions) are characteristic of the thermal denaturation of proteins (3) and the heat inactivation of enzymes (38) and viruses (18) . There is, therefore, a definite suggestion that, at about 60°C., thrombin is directly influenced by heating. This would be the case if thrombin were a protein, or so closely associated with proteins as to be affected by their thermal denaturation. Strong thrombin preparations may retain a fair degree of activity, however, even after boiling for a few minutes (8) . The presence of water is apparently essential for denaturation (3) . When dried, thrombin preparations are much more stable to heating (21) and storing (35, 30) than when in solution.
There is an unexplained variability between the different thrombin preparations (Table IV) . In enzyme systems, which show analogous behavior, such variability is often associated with the impurities present in the preparations, although many of the essential data are the same for crude preparations as for highly purified enzymes (37) . In analogous systems, we also have the suggestion of specific intramolecular groups which act as negative catalysts (inhibitors), their effectiveness being lessened by dilution (18) . Such an explanation may account for the greater stability of highly concentrated thrombin solutions, and for the marked deviations from the inverse law which they exhibit.
The k values for the data on temperature effects were obtained at constant pH. It has been pointed out that, for certain thermal denaturation reactions (e.g. pepsin), where the rate varies with the hydrogen ion concentration, the practice of measuring the critical thermal increment at constant pH gives an unduly high value due to the inclusion of "the heat of dissociation of all acidic equilibria involved in preparing the initial molecules for the kinetic step of activation" (La Mer, 20). Since our preparations are admittedly crude, we do not propose to elaborate upon temperature and pH interrelationships, but merely to state that the calculations for the critical thermal increment are subject to a correction. The effect of pH on the velocity constant is dealt with in the following section.
(B). pH.--In studying the influence of hydrogen ion concentration on the rate of thrombin inactiva-150I /
/ pH

FIG. 3. Effect of pH on the velocity constants of various thrombin preparations (temperature 38°).
tion, the thrombin preparations are adjusted to definite pH values (with the glass electrode) and the inactivation rate is measured at 38°C. All clotting tests are made on fibrinogen, buffered with barbital at pH = 7.2. The results are given in Fig. 3 .
In all cases, the rate of inactivation below a pH of about 3.5 is too great for measurement. The acid-inactivated thrombin is not reactivated by neutralization. The most stable thrombin preparations show very little change of k between pH 5.0 to 10.0. Unstable preparations, including those to which trypsin or serum was added (see below), are most stable at pH of
Influence of Added Trypsin
Crystalline trypsin (26) is a purified preparation of a well known protease, which has a recognized ability to destroy thrombin (7, 11) .
In the experiments illustrated in Fig. 4 , known amounts of crystalline trypsin were added to thrombin, at pH = 8.2 and temperature = 38°C. The k values were computed, as usual, from the clotting times, at various periods after the addition of trypsin. It is evident that the k values increase in direct proportion to the amount of trypsin added.
The similarity of the calculated and observed values for k in Table V proportional to the trypsin present, as well as to the concentration of thrombin (equation 3). The full results may now be expressed as follows:
differing from equation 3, in the introduction of the factor L, which represents the concentration of the thrombinolytic factor (trypsin). This equation describes a first order inactivation reaction and is a generalized equation representing the kinetics of progressive thrombin inactivation. It is obvious that once a thrombin unit is chosen, the lysin unit is readily defined.
Influence of Serum
The classical studies of Howell (17) , and the long-forgotten but significant data of Collingwood and MacMahon (4), include mention of the progressive character of the antithrombic action of serum. Heating serum to 60°C. for a few minutes is said to destroy most of the antithrombic properties. Howell's contention that the action is associated with the serum proteins is supported by Quick (29) , who, contrary to Howell and his pupils, finds a thermolabile "albumin" fraction effective. In our earlier experiments (12) no significant antithrombic action was demonstrable with a crude plasma albumin (sans heparin). We have recently (13) confirmed this by incubating similar crude plasma albumin with a stable thrombin for a full hour, at 24°C., and noting only a 15 second increase over the original dotting time of 18 seconds (maintained unchanged in the control). Tests have also been made with a pure crystalline serum albumin, kindly supplied by Dr. T. L. McMeekin (Harvard), which fail to demonstrate any significant antithrombic action alone, and (in sharp contrast to crude albumin) in the presence of heparin. We subscribe, therefore, to the belief that antithrombin is not serum albumin, but some unknown factor which may or may not be associated with it.
Since Quick's experiments (29) , like those of M0rawitz (25), support claims for antithrombin in plasma by procedures involving a preliminary defibrination, it cannot be asserted with any degree of certainty that untreated plasma contains an active antithromhin. Some of our results indicate that the antithrombin in plasma is present as an inactive substance.
The present kinetic studies on serum antithrombin involve two methods, (a) following the concentration of thrombin present in serum from the earliest practicable moment after defibrination, and (b) adding varying amounts of a thrombin-free (tested) serum to a known thrombin preparation.
Preparalbm of Serum.--Acetone-thromboplastin (see reagents) is added to citrated plasma diluted with 0.85 per cent NaCI, and recalcified with an optimal amount of CaCI2. The fibrin is removed with a glass rod as fast as it is formed. The addition of a few drops of thrombin to a sample of the final serum confirms the completeness of the defibrination.
Tests.--(a) Immediately upon completion of the defibrination, 0.5 cc. of serum is added to 1 cc. of fibrinogen solution, under the conditions previously described for thrombin assay, and the test is repeated at various time intervals. (b) For the second series of experiments, increasing amounts of serum (thrombin-free, by tests on fibrinogen) are added to thrombin and the kinetics followed in the usual way.
(a).-- Table VI shows that the inactivation rate constant (k) for the naturally occurring thrombin of serum is exceedingly high. The inactivation rate for thrombin in serum appears to be directly dependent upon the initial concentration of the plasma.
Hemophilia.--The serum from a citrated hemophilic plasma was diluted tenfold and clotted by CaCI~, both with and without added thromboplastin.
TABLE VI
Rate of Thrombin Inactivation in Serum (pH = 7.4; Temperature = 38 °)
Brain thromboplastin was added to dog plasma before recalcifying. Incubation time is given in minutes, measured from the time of recalcification. The clotting time is given in seconds in the body of the table. Table VII , increasing amounts of thrombin-free serum were added to a thrombin solution and the kinetics of inactivation studied. The results clearly show the ability of serum to increase the thrombin inactivation rate. The k value rises in direct proportion to the amount of serum added. It may also be noted that the 24 hour old serum preparation used for the data of Table VII, Series B, is much weaker than the fresh serum of Table VII, Series A. This suggests a lability of the thrombinolytic factor in serum and lessens the bare possibility of the inactivation process being some sort of combination or adsorption on to the serum proteins (19, 31) . The inability to reactivate serum-lysed thrombin with alkali or acid (cf. "metathrombin," 25, 17) also argues strongly against a non-lyric inactivation mechanism.
The rate of decrease of the antithrombic a~ti~ty of serum was studied at different pH levels, but constant temperature (38°C.). 1 cc. of each serum sample, held at the chosen pH for the cited times, was added to 5 cc. of a stable thrombin, buffered at pH = 7.6 with imidazole buffer (see reagents). The thrombin inactivation rates were determined in the usual manner. The results are presented in Table VIII. Although more antithrombic activity was initially present at pH = 9.8 than in sera kept at low pH values, there was more rapid loss of antithrombic activity at the most alkaline pH. At pH 5.4 and 7.4 a small increase in antithrombic activity is apparent. At pH values below 4.0, there was practically no antithrombic activity. This was not due to the previously described effect of acids on thrombin (see above), since the thrombin itself was well buffered at pH = 7.6. The sera kept for over 2 hours at pH levels of 2.0 and 3.9 did not regain their antithrombic activity during the incubation with the thrombin at pH = 7.6. However, the loss of antithrombin is reversible, under appropriate conditions, as shown by the data of Table IX .
Here the serum was brought to pH = 1.7. After standing for about 10 minutes, a portion was brought to pH = 9.6 and allowed to stand at ., for 30 minutes; the rest was kept (at pH = 1.7) as a control. 1 cc. of each sample was then added to 5 cc. of thrombin, at pH = 7.6, and the thrombin inactivation rate measured as before. The alkalinized preparation recovered a marked degree of antithrombic activity, whereas there was a complete absence of antithrombin in the acid sample, as seen by comparing with the thrombin control. The similarity of these pH effects to those obtaining with trypsin (Northrop, 26) is remarkable.
DISCUSSION
It is evident from the foregoing experiments that prepared thrombins undergo progressive inactivation, following the course of a first order reaction. By computing the velocity constant (k) from kinetic data, the process may be characterized independently of the factor of thrombin concentration. Since k may vary greatly in thrombins which are similar in initial activity, there is strong evidence for a thrombinolytic factor, which varies from preparation to preparation. The obvious suggestion is that it must be regarded as an "impurity" in the thrombin.
The proteolytic enzyme trypsin is an example of added impurity, which can alter the kinetic behavior of a stable thrombin to that of one which is much less stable. The so called antithrombic action of serum closely resembles that of trypsin in the studies we have made concerning its kinetic aspects. The physical conditions of temperature and pH, which are so important in thrombin formation, are no less significant in modifying thrombin inactivation. Whereas the most stable thrombins retain their activity over a wide pH range (5.0-10.0), the less stable preparations (including those to which trypsin or serum has been added) show a maximum stability at pH = 4-5.
The chief interest in the facts herein presented lies in the explanation which must be offered to account for them and in the future lines of enquiry to which they clearly point. Chief among the latter will be the attempt to isolate the thrombin impurity (antithrombin), which is indicated by the data. Pending the outcome of investigations now proceeding, by which it is hoped to characterize the thrombinolytic factor from the viewpoint of its proteolytic activities, we are advancing only tentatively the conclusion that progressive antithrombic action may be due to an enzyme impurity in the thrombin (and prothrombin) preparations?
The following summarized points constitute the present evidence in support of this conclusion:
1. Added trypsin, like serum antithrombin, converts a stable thrombin into an unstable one, with a marked increase in the inactivation rate constant.
2. The acidic region (pH = 4-5) at which unstable thrombins are most slowly inactivated is the pH zone at which the effects of trypsin and serum are minimal. Northrop (26) has pointed out that pure trypsin is inactive in this pH region.
3. The inactivating agent (serum antithrombin) appears to be most stable at pH 5 to 6.
4. The unimolecular behavior of the inactivation process, together with the effects of varying physical conditions, are wholly consistent with the enzyme hypothesis.
It is not intended to place the whole burden of thrombin inactivation upon the postulated thrombinolytic enzyme. The slow deterioration of the more stable thrombins may very well be a protein denaturation. Thermal denaturation of proteins, enzymes, and viruses (some of which are now known to be proteins) follows a very similar course. The rapid inactivation, especially at moderate temperatures, in the physiological pH range, is the main reason, apart from the analogies outlined above, for postulating a specific thrombinolytic factor.
We do not know what thrombin is, but all the available evidence indicates that it is a protein, or so closely bound up with proteins as to be affected by their susceptibility to denaturation and proteolysis. Thrombin may also be an enzyme, although definite proof for, or against, this is still lacking (27) . We have previously (11) advanced the idea that another type of enzyme, viz. a thromboplastic enzyme, accompanies (crude) prothrombin and, in conjunction with ionized calcium and phospholipid (cephalin), activates it to thrombin. The present data indicate yet another enzymatic function, namely, thrombinolytic. This need not complicate the picture unduly, if it should turn out to be identical with the thromboplastic factor, and especially if both are tryptic. Plasma tryptases are already known (Schmitz, 33) and might very well be expected to accompany plasma prothrombin and thrombin preparations. Schmitz's work raises the question of the r61e of specific inhibitors (antitrypsins), and kinase factors, in these new functions we are postulating for plasma tryptase. Upon the answer to this question may hinge the explanation of the continued fluidity of the blood in vivo.* Tissue (including platelet and possibly leucocyte) sources of protease are not immediately involved in our Berkefelded plasma reagents, with cephalin as the only added thromboplastic agent. However, tissue antithrombins have been described in the literature. These may very well depend upon artificial methods of preparation and will require more extensive investigation than the data here presented. It may be significant that brain extracts are known to contain an antitrypsin (28) . The data of Fig. 2 and Table III do not lend strong support to Howell's view that thromboplastin "neutralizes" antithrombin, but Howell himself had certain doubts, e.g., the inability of cephalin to overcome the serum inhibitor of fully formed thrombin (17) .
It is not proposed to take up space to contrast our thrombinolytic antithrombin theory with older views which postulate a loose thrombinantithrombin "combination" (? metathrombin formation). Our inactivated thrombins are irreversible and unaffected by treatment with alkali and acid (of. metathrombin). All the evidence points to the progressive action of a specific antithrombin, rather than to the progressive production of an immediate antithrombin.
We have often observed that clots formed in the presence of unstable thrombins are especially liable to undergo fibrinolysis. Correlation of fibrinolysis with thrombinolysis is, therefore, suggested.
We are currently engaged in an attempt to use the basic methods of this paper in a simple clinical test for progressive antithrombins. Provided that a practical thrombin unit can be (empirically) established, a unit of antithrombin can readily be defined from equation 10. SUMMARY 1. A new technique for studying the progressive inactivation of thrombin is described.
2. Thrombin inactivation follows the kinetics of a first order reaction.
3. The rate constant of the inactivation reaction increases with temperature and pH (5.0 --+ 10.0), and also with the presence of crystalline trypsin, or serum. The rate varies for different thrombin preparations, even under the same experimental conditions. 4. The temperature characteristics of the reaction indicate that thrombin is associated with protein.
5. Thrombin preparations are most stable at pH 4 to 5, even when trypsin or serum is added.
6. The progressive inactivation is believed to be due to two mechanisms: (1) a major effect, thought to be the action of a "serum-tryptase," which is usually present in the thrombin preparations, and (2) a minor effect, probably attributable to denaturation of thrombin-protein.
7. Sources of the thrombinolytic factor (serum-tryptase) and its implications in the general theory and practical problems of blood coagulation and antithrombic action are briefly discussed.
